Home » Topics » Regulatory » EMA

EMA
RSS

CHMP adopts positive trend vote recommending the approval of the MAA for neratinib

June 27, 2018

EMA validates Giapreza MAA

June 26, 2018

EMA grants PRIME designation for Themis' Chikungunya vaccine

June 12, 2018

FDA and EMA accepts regulatory submissions of talazoparib for review

June 8, 2018

EMA grants PRIME designation for dilanubicel

June 7, 2018

EMA grants PRIME designation to AT-132 for the treatment of X-linked myotubular myopathy

June 6, 2018

Myalepta receives positive CHMP opinion for generalized and partial lipodystrophy

June 5, 2018

EMA committee backs approval of trastuzumab biosimilar Trazimera

June 4, 2018

EMA committee recommends approval of Translarna for younger children with DMD

June 4, 2018

EMA CHMP recommends approval of Sandoz adalimumab biosimilar

June 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...